Praveena Baireddy

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
N-methyl-D-aspartate (NMDA) receptor antagonists, including open channel blockers and GluN2B receptor subtype selective antagonists, have been developed for the treatment of depression. The current study investigated effects of systemically administered NMDA channel blockers and GluN2B receptor antagonists on NMDA receptor activity in rodents using in vivo(More)
  • 1